TABLE 1.

Characteristics of convalescent donors used for IFN‐γ assay in response to SARS‐CoV‐2 peptides

Donor	Age	Sex	IgG	Blood type	Time after COVID−19	Severity
D1	50	M	5·9	0−	–
D2	58	M	5·21	0+	4 months
D2 bis	58	M		0+	9 months
D3	30	M	5·24	A+	3 months	Moderate
D4	41	H	7·62	A−	–
D5	59	H	6·7	A+	5 months
D6	60	H	7·1	A+	–